Nvidia and QIA-backed Iambic Therapeutics Files for IPO in the US
📊 NVDA — Piyasa Yorumu
▲ up · 55%Nvidia-backed Iambic Therapeutics' IPO filing confirms the value of Nvidia's strategic investments in the AI and drug discovery ecosystem. Although the news does not directly affect Nvidia's financials, it could create a positive sentiment in the short term by strengthening the perception of success in the company's investment portfolio. Technical indicators already point to a strong uptrend: the price is above the 20- and 50-day moving averages, MACD is above the signal line, and RSI at 78 is in overbought territory. While the overbought condition increases the risk of a short-term correction, the news impact may be limited positive. Therefore, I assess the direction as 'up', but with a moderate confidence level.
📊 GOOGL — Piyasa Yorumu
■ neutral · 35%The news announces an IPO filing not directly related to GOOGL; therefore, its impact on the stock may be limited and indirect. Technical indicators are positive: the price is above the SMA20 and SMA50, RSI at 63 is approaching overbought territory, and MACD is above the signal line. In the short term, upward momentum may continue, but the RSI level increases the risk of a correction. Since the news is not a direct catalyst, directional uncertainty is high. Therefore, a neutral outlook stands out.